Compare Stocks

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
JAN JanOne	$3.70 +1.1%	$2.12	$0.22 ▼ $4.08	$31.78M	2.34	259,579 shs	149,793 shs

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
JAN JanOne	-4.19%	+29.33%	+30.25%	+603.85%	+269.70%

Don’t expose yourself to stocks during the week (Ad)

The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.

Click here and I’ll give you all the details.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
JAN JanOne	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
JAN JanOne	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
JAN JanOne	$39.61M	0.80	N/A	N/A	($0.67) per share	-5.52

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
JAN JanOne	-$7.81M	N/A	0.00	∞	N/A	N/A	-177.90%	-55.98%	5/27/2024 (Estimated)

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
JAN JanOne	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
JAN JanOne	N/A	0.06	0.06

Ownership

Institutional Ownership

Company	Institutional Ownership
JAN JanOne	6.27%

Insider Ownership

Company	Insider Ownership
JAN JanOne	3.00%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
JAN JanOne	199	8.59 million	8.34 million	Not Optionable

JAN, EVS, CER, and ZOO Headlines

Source	Headline
	JanOne Regains Compliance with Nasdaq's Listing Requirements prnewswire.com - March 15 at 9:00 AM
	Why ZoomInfo Technologies Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket msn.com - February 13 at 10:09 AM
	JanOne, Inc. Revises Promissory Notes and Issues New Debt msn.com - February 9 at 10:45 AM
	JanOne: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits cbonds.com - January 14 at 3:51 AM
	Local history books donated to Canton School District thedailyreview.com - January 13 at 9:47 AM
	JanOne Inc JAN morningstar.com - December 23 at 2:06 PM
	Canton School Board reorganizes, swears in new member thedailyreview.com - December 11 at 7:20 AM
	Why Is Assertio (ASRT) Stock Down 39% Today? msn.com - November 9 at 9:41 AM
	N.J. general election results 2023: Morris County nj.com - November 7 at 9:50 PM
	KCFCA partners with school districts thedailyreview.com - October 25 at 4:16 AM
	Canton Township partners with school district thedailyreview.com - October 5 at 8:58 AM
	JanOne to Present at the Dawson James 8th Annual Investment Conference finance.yahoo.com - September 21 at 3:01 PM
	JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference finance.yahoo.com - August 31 at 5:18 PM
	JanOne Shares Jump 16% After Obtaining U.S. Patent for Jan123 to Treat Chronic Pain marketwatch.com - August 29 at 4:35 PM
	JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain finance.yahoo.com - August 29 at 4:35 PM
	JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting finance.yahoo.com - August 25 at 5:35 PM
	JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules finance.yahoo.com - August 22 at 9:23 PM
	JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules finance.yahoo.com - August 18 at 9:23 PM
	JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting finance.yahoo.com - August 18 at 4:23 PM
	Red Bank Council Authorizes Resolution For Senior Center Preservation tworivertimes.com - June 28 at 10:17 AM
	JanOne Files Intl Patent Application For Low Dose Naltrexone For Chronic Pain markets.businessinsider.com - June 28 at 10:17 AM
	JanOne files international patent application for methods of using low dose naltrexone to treat chronic pain finance.yahoo.com - June 28 at 10:17 AM
	Used RAM trucks for sale in Hillsdale, NJ cars.com - June 13 at 8:44 PM
	Used Subaru Outback for sale in Independence, NJ cars.com - June 8 at 1:50 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Canoo, Inc. Bites the Dust: Mullen Automotive Is a Better Bet
April 2, 2024 9:15 AM
View Canoo, Inc. Bites the Dust: Mullen Automotive Is a Better Bet
Wendy’s Stock Could Be Your Best Passive Income Stock
April 9, 2024 7:45 AM
View Wendy’s Stock Could Be Your Best Passive Income Stock
Tesla Stock Drops on Weak Delivery Numbers and it May Fall More
April 2, 2024 11:25 AM
View Tesla Stock Drops on Weak Delivery Numbers and it May Fall More
Trump Media & Technology Group Soars on Market Debut
March 26, 2024 1:05 PM
View Trump Media & Technology Group Soars on Market Debut
Tesla Is the Analyst's Most Downgraded Stock: How Low Can It Go?
March 26, 2024 7:00 AM
View Tesla Is the Analyst's Most Downgraded Stock: How Low Can It Go?

All Headlines

Company Descriptions

JanOne

NASDAQ:JAN

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through Biotechnology and Recycling segments. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial